Immunotech Biopharm (HKSE:06978) 3-Year EBITDA Growth Rate : 19.90% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Immunotech Biopharm 3-Year EBITDA Growth Rate?

Immunotech Biopharm's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.45.

During the past 3 years, the average EBITDA Per Share Growth Rate was 19.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -47.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Immunotech Biopharm was 19.90% per year. The lowest was -128.30% per year. And the median was -40.10% per year.

Competitive Comparison of Immunotech Biopharm's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Immunotech Biopharm's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunotech Biopharm's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunotech Biopharm's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Immunotech Biopharm's 3-Year EBITDA Growth Rate falls into.

Immunotech Biopharm 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Immunotech Biopharm (HKSE:06978) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Immunotech Biopharm 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Immunotech Biopharm's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunotech Biopharm (HKSE:06978) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunotech Biopharm Ltd (HKSE:06978) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Kangding Street, 8th Floor, Block 1, Guosheng Technology Park, Beijing Economic-technological Development Area, Beijing, CHN, 100176

Website

http://www.eaal.net

Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

Executives

Jung Hyun Chul
Evodevo Ltd
Tian Jin He Yue Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Wu Naifeng	2501 Other
Yan Kaijing	2501 Other
Yan Xijun	2501 Other
Tian Shi Li Kong Gu Ji Tuan You Xian Gong Si	2501 Other
Tian Shi Li Yi Yao Ji Tuan Gu Fen You Xian Gong Si	2501 Other
Tian Jin Di Zhi Tou Zi Guan Li You Xian Gong Si	2501 Other
Tian Jin Fu Hua De Ke Ji Kai Fa You Xian Gong Si	2501 Other
Li Yunhui	2501 Other
Tian Jin Hong Xun Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Kang Shun Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Shan Zhen Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other
Tian Jin Shun Qi Ke Ji Fa Zhan He Huo Qi Ye You Xian He Huo	2501 Other

Immunotech Biopharm (HKSE:06978) Headlines

No Headlines